The Current Ratio as of June 2026 (TTM) for Arcturus Therapeutics Holdings Inc. (ARCT) is 6.31

According to Arcturus Therapeutics Holdings Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.31. This represents a change of -5.50% compared to the average of 6.68 of the last 4 quarters.

Arcturus Therapeutics Holdings Inc. (ARCT) Historical Current Ratio (quarterly & annually)

How has ARCT Current Ratio performed in the past?

The mean historical Current Ratio of Arcturus Therapeutics Holdings Inc. over the last ten years is 5.57. The current 6.31 Current Ratio has changed 11.23% with respect to the historical average. Over the past ten years (40 quarters), ARCT's Current Ratio was at its highest in in the June 2017 quarter at 25.42. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Arcturus Therapeutics Holdings Inc. (ARCT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Arcturus Therapeutics Holdings Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arcturus Therapeutics Holdings Inc. (ARCT) Average Current Ratio

How has ARCT Current Ratio performed in the past?

The current Current Ratio of Arcturus Therapeutics Holdings Inc. (ARCT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Arcturus Therapeutics Holdings Inc. (ARCT) Current Ratio vs. Peers

How is ARCT’s Current Ratio compared to its peers?

Arcturus Therapeutics Holdings Inc.’s Current Ratio is less than Sagimet Biosciences Inc. (20.34), greater than Humacyte, Inc. (3.93), less than Voyager Therapeutics, Inc. (8.42), less than Entrada Therapeutics, Inc. (13.90), greater than Vanda Pharmaceuticals Inc. (2.16), greater than Achieve Life Sciences, Inc. (2.62), greater than Foghorn Therapeutics Inc. (2.92), less than Immuneering Corporation (32.45), less than Zura Bio Limited (19.33), less than Atea Pharmaceuticals, Inc. (7.89),

Build a custom stock screener for Arcturus Therapeutics Holdings Inc. (ARCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arcturus Therapeutics Holdings Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arcturus Therapeutics Holdings Inc. (ARCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arcturus Therapeutics Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.